Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry

Journal Title: DARU Journal of Pharmaceutical Sciences - Year 2012, Vol 20, Issue 0

Abstract

In 1980s, medicines produced through recombinant DNA technology created a novel opportunity for management of several debilitating and life threatening diseases. However, these medicines are very expensive and therefore not affordable for many patients especially those living in low resourced countries. Biopharmaceuticals mostly have a high unit cost and often prescribed for chronic medical conditions with possibility of long-term use.

Authors and Affiliations

Abdol Majid Cheraghali

Keywords

Related Articles

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

Metabolic and cardiovascular side effects have been noted with the use of second generation antipsychotics (SGAs) and mood stabilizers. Since Omega-3 fatty acids have been known to prevent some cardiovascular risks, this...

The role of prophylactic ibuprofen and N-acetylcysteine on the level of cytokines in periapical exudates and the post-treatment pain

Periapical lesions are inflammatory diseases that result in periapical bone destruction because of host defensive-microbial disturbances. Objective To evaluate the role of prophylactic ibuprofen and N-acetylcysteine (NA...

Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety

Background and the purpose of the study Piperazinyl quinolones such as ciprofloxacin, ofloxacin and levofloxacin are an important group of quinolone antimicrobials which are widely used in the treatment of various infect...

Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design

Background and purpose of the study Glimepiride (GLM) was chosen as a model substrate in order to determine the kinetic parameters for in vitro metabolism via human liver micrososmes (HLM). We aimed to optimize the turno...

Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-flurouracil formulations for buccal, vaginal and rectal application

The present investigation was designed with the intention to formulate versatile 5-flurouracil (5-FU) matrix tablet that fulfills the therapeutic needs that are lacking in current cancer treatment and aimed at minimizing...

Download PDF file
  • EP ID EP150956
  • DOI -
  • Views 109
  • Downloads 0

How To Cite

Abdol Majid Cheraghali (2012). Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry. DARU Journal of Pharmaceutical Sciences, 20(0), 1-8. https://europub.co.uk./articles/-A-150956